Overview
Robert Mayer is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Mayer is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Colorectal Cancer, Fibrolamellar Carcinoma, Lynch Syndrome, and Agranulocytosis. Dr. Mayer is currently accepting new patients.
His clinical research consists of co-authoring 95 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Fibrolamellar Carcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Andrew Zhu is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Liver Cancer.
Keith Stuart is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Stuart is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Colorectal Cancer, Familial Colorectal Cancer, Familial Pancreatic Cancer, and Liver Embolization. Dr. Stuart is currently accepting new patients.
Pratt Medical Group Inc
Francis Nugent is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Nugent is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Gastrostomy. Dr. Nugent is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Colorectal CancerDr. Mayer isElite. Learn about Colorectal Cancer.
- Distinguished
- Fibrolamellar CarcinomaDr. Mayer isDistinguished. Learn about Fibrolamellar Carcinoma.
- Advanced
- AgranulocytosisDr. Mayer isAdvanced. Learn about Agranulocytosis.
- Familial Colorectal CancerDr. Mayer isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Mayer isAdvanced. Learn about Familial Pancreatic Cancer.
- Gastroesophageal Junction Cancer
- Lynch SyndromeDr. Mayer isAdvanced. Learn about Lynch Syndrome.
- Pancreatic CancerDr. Mayer isAdvanced. Learn about Pancreatic Cancer.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Mayer isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Anal CancerDr. Mayer isExperienced. Learn about Anal Cancer.
- Appendix CancerDr. Mayer isExperienced. Learn about Appendix Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Mayer isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Chronic B-Cell Leukemia (CBCL)Dr. Mayer isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Mayer isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).